Rchr
J-GLOBAL ID:202201004257934000   Update date: Jan. 30, 2024

Matsushita Yosuke

Matsushita Yosuke
Research theme for competitive and other funds  (6):
  • 2022 - 2025 Development of biomarkers and new treatments for metastatic breast cancer by eribulin
  • 2021 - 2024 新規家族性乳がん感受性遺伝子の同定と既知原因遺伝子のVUSリスク評価法の確立
  • 2018 - 2021 Identification of recurrent genetic and epigenetic alterations of SALL3 in TNBC by comprehensive genomic analysis
  • 2017 - 2019 Drug discovery in breast cancer utilizing reactivation of tumor suppressors
  • 2016 - 2019 Clarification of novel pathophysiological roles of BIG3 in breast cancer cells
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page